X4 Pharmaceuticals Inc (NASDAQ: XFOR) on Friday, plunged -0.22% from the previous trading day, before settling in for the closing price of $0.81. Within the past 52 weeks, XFOR’s price has moved between $0.26 and $1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -20.00%. The company achieved an average annual earnings per share of 77.49%. With a float of $117.85 million, this company’s outstanding shares have now reached $168.51 million.
Let’s determine the extent of company efficiency that accounts for 93 employees. In terms of profitability, gross margin is 85.2%, operating margin of -618.81%, and the pretax margin is -398.61%.
X4 Pharmaceuticals Inc (XFOR) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of X4 Pharmaceuticals Inc is 30.90%, while institutional ownership is 35.58%. The most recent insider transaction that took place on Nov 15 ’24, was worth 12,583. In this transaction President and CEO of this company sold 31,897 shares at a rate of $0.39, taking the stock ownership to the 993,919 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Officer proposed sale 31,897 for $0.41, making the entire transaction worth $13,078.
X4 Pharmaceuticals Inc (XFOR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.49% per share during the next fiscal year.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
X4 Pharmaceuticals Inc (XFOR) is currently performing well based on its current performance indicators. A quick ratio of 4.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 122.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Looking closely at X4 Pharmaceuticals Inc (NASDAQ: XFOR), its last 5-days average volume was 3.45 million, which is a jump from its year-to-date volume of 2.47 million. As of the previous 9 days, the stock’s Stochastic %D was 62.74%. Additionally, its Average True Range was 0.11.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 88.26%, which indicates a significant increase from 84.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 245.20% in the past 14 days, which was higher than the 180.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5137, while its 200-day Moving Average is $0.7940. However, in the short run, X4 Pharmaceuticals Inc’s stock first resistance to watch stands at $0.8525. Second resistance stands at $0.9012. The third major resistance level sits at $0.9424. If the price goes on to break the first support level at $0.7626, it is likely to go to the next support level at $0.7214. Now, if the price goes above the second support level, the third support stands at $0.6727.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
Market capitalization of the company is 136.79 million based on 170,546K outstanding shares. Right now, sales total 0 K and income totals -101,170 K. The company made 560 K in profit during its latest quarter, and -36,700 K in sales during its previous quarter.
